The clinical research program at Georgia Cancer Specialists focuses on making targeted cancer therapy accessible to as many patients as possible. With seven research sites in Metro Atlanta, Macon, Athens, and Blairsville, patients across the state are able to take part in cutting-edge clinical trials targeting all types of cancer, including lung cancer, breast cancer, lymphoma, colon cancer, and prostate cancer.
Because of our strong commitment to research, GCS is affiliated with the Northside Hospital Cancer Institute, one of one of only 21 cancer programs in the United States to be selected by the National Cancer Institute to participate in the NCI Community Cancer Centers Program (NCCCP). As a NCCCP, GCS and the Northside Hospital Cancer Institute will seek to increase patient participation in clinical trials and promote genomically-informed research (also known as personalized medicine).
Through an affiliation with the University of Alabama-Birmingham Comprehensive Cancer Center (UABCCC), GCS is able to offer leading-edge cancer care to GCS patients. GCS is the only private cancer practice in Georgia to offer Phase I clinical trials.